Latest

Insilico Drug Repurposing Approach To Identify Drugs For The Treatment Of Neglected Diseases using PRinS3® Platform

Chagas Disease can be described as a condition in which the parasite named Trypanosoma cruzi is involved and is the main causative agent of this disease.

Posted on: by Medha Dwivedi

Identifying New Chemical Entities as Potential Therapeutic Agent for NAFLD Treatment using PRinS3® Platform

Non-alcoholic fatty liver disease, a chronic liver condition not caused by alcohol or other obvious liver-damaging factors, is characterized by excessive fat deposition in hepatocytes.

Posted on: by Megha Bose

Exploring Natural Products that inhibit the Target Biliverdin Reductase in Hyperbilirubinemia using PRinS3® Platform

Hyperbilirubinemia is a form of illness characterized by an increase in blood bilirubin levels as a result of a failure to efficiently metabolize or eliminate bilirubin, a byproduct of erythrocyte breakdown. It can be traced back to irregularities in normal bilirubin metabolism.

Posted on: by Sakshi Singh

Featured

Exploring Natural Products that inhibit the Target Biliverdin Reductase in Hyperbilirubinemia using PRinS3® Platform

The traditional procedure of discovering new drugs is challenging and time-consuming, often have very low success rates at that.

Posted on: by Sakshi Singh